Bioalpha Holdings Berhad

KLSE:BIOHLDG Stok Raporu

Piyasa değeri: RM 91.4m

Bioalpha Holdings Berhad Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Bioalpha Holdings Berhad.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Personal Products kazanç büyümesi17.7%
Gelir büyüme oranın/a
Gelecekteki özkaynak getirisin/a
Analist kapsamı

None

Son güncellemen/a

Gelecekteki son büyüme güncellemeleri

Recent updates

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) A Risky Investment?

Mar 19
Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) A Risky Investment?

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Oct 04
Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) Using Debt Sensibly?

Jun 20
Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) Using Debt Sensibly?

Bioalpha Holdings Berhad (KLSE:BIOHLDG) Is Using Debt Safely

Mar 01
Bioalpha Holdings Berhad (KLSE:BIOHLDG) Is Using Debt Safely

Why Bioalpha Holdings Berhad (KLSE:BIOHLDG) Could Be Worth Watching

Mar 29
Why Bioalpha Holdings Berhad (KLSE:BIOHLDG) Could Be Worth Watching

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Mar 03
Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Can You Imagine How Bioalpha Holdings Berhad's (KLSE:BIOHLDG) Shareholders Feel About The 42% Share Price Increase?

Jan 20
Can You Imagine How Bioalpha Holdings Berhad's (KLSE:BIOHLDG) Shareholders Feel About The 42% Share Price Increase?

How Much Is Bioalpha Holdings Berhad's (KLSE:BIOHLDG) CEO Getting Paid?

Nov 28
How Much Is Bioalpha Holdings Berhad's (KLSE:BIOHLDG) CEO Getting Paid?

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Bioalpha Holdings Berhad yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

KLSE:BIOHLDG - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (MYR Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
6/30/202459-37-7-3N/A
3/31/202445-3226N/A
12/31/202346-42-21N/A
9/30/202340-52-60N/A
6/30/202335-56-14N/A
3/31/202335-61-12-6N/A
12/31/202236-48-11-4N/A
9/30/202238-24-12-8N/A
6/30/202259-16-16-8N/A
3/31/202282-7-16-4N/A
12/31/202197-1-20-4N/A
9/30/2021100-13-22-2N/A
6/30/202178-25-23-6N/A
3/31/202155-34-21-3N/A
12/31/202036-41-19-2N/A
9/30/202040-22-1011N/A
6/30/202050-8-814N/A
3/31/2020582-911N/A
12/31/2019648-916N/A
9/30/2019629-168N/A
6/30/20196510-1713N/A
3/31/20197012-1514N/A
12/31/20187012-1510N/A
9/30/20187213-812N/A
6/30/20186612-812N/A
3/31/20186010N/A11N/A
12/31/2017568N/A20N/A
9/30/2017528N/A10N/A
6/30/2017507N/A14N/A
3/31/2017496N/A11N/A
12/31/2016478N/A1N/A
9/30/2016418N/A14N/A
6/30/2016378N/A8N/A
3/31/2016337N/A6N/A
12/31/2015307N/A5N/A
9/30/2015286N/A6N/A
6/30/2015285N/A2N/A
3/31/2015287N/A7N/A
12/31/2014276N/A6N/A
12/31/2013256N/A5N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if BIOHLDG's forecast earnings growth is above the savings rate (3.6%).

Kazançlar ve Piyasa: Insufficient data to determine if BIOHLDG's earnings are forecast to grow faster than the MY market

Yüksek Büyüme Kazançları: Insufficient data to determine if BIOHLDG's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if BIOHLDG's revenue is forecast to grow faster than the MY market.

Yüksek Büyüme Geliri: Insufficient data to determine if BIOHLDG's revenue is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if BIOHLDG's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin